Bonum Therapeutics
Seattle, United States· Est.
Bonum Therapeutics creates targeted protein degradation therapies using proprietary platforms to address oncology and inflammatory diseases.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $93M
About
Bonum Therapeutics creates targeted protein degradation therapies using proprietary platforms to address oncology and inflammatory diseases.
OncologyImmunologyProteomics
Funding History
1Total raised:$93M
Venture$93M